Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · page 30 of 50
The slide uses an antibody diagram to annotate specific technical advantages of the SPY002 molecule.
Deck · key_messages · present_solution · dense density
Slide locked Sign in to view
Slide schematic 7/7
image 1/1 list 4/4 table 1/1 title 1/1
Components 7
illustration bullet bullet bullet bullet data headline
Tools 2
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.